Atherosclerosis: Pathogenesis and pathology

Diagnostic Histopathology

Volumn 18, Issue 11, 2012, Pages 461-467

  Wang, Tao ^a   Palucci, Daniel ^b   Law, Kelsey ^c   Yanagawa, Bobby ^d   Yam, Jennifer ^e   Butany, Jagdish ^e  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c RYERSON UNIVERSITY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Atherosclerosis; Complications of atherosclerosis; Endothelial cells

Indexed keywords

BIOLOGICAL MARKER; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MATRIX METALLOPROTEINASE;

ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CALCIFICATION; CARDIOVASCULAR RISK; CELL MIGRATION; CEREBROVASCULAR DISEASE; CORONARY ARTERY DISEASE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM INJURY; EXTRACELLULAR MATRIX; GENETIC ASSOCIATION; GENETIC SCREENING; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LIPID STORAGE; MORBIDITY; MORTALITY; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PERIPHERAL VASCULAR DISEASE; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

EID: 84869878257     PISSN: 17562317     EISSN: 18767621     Source Type: Journal    
DOI: 10.1016/j.mpdhp.2012.09.004     Document Type: Article

References (25)

1. Vanhoutte P.M. Endothelial dysfunction; the first step toward coronary arteriosclerosis. Circ J 2009, 73:595-601.
2. Deanfield J.E., Halcox J.P., Rabelink T.J. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007, 115:1285-1295.
3. Sima A.V., Stancu C.S., Simionescu M. Vascular endothelium in atherosclerosis. Cell Tissue Res 2009, 335:191-203.
4. Mannarino E., Pirro M. Endothelial injury and repair: a novel theory for atherosclerosis. Angiology 2008, 59(2 suppl):69S-72S.
5. Tsimikas S., Miller Y.I. Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease. Curr Pharm Des 2011, 17:27-37.
6. Nissen S.E., Tardif J.C., Nicholls S.J., et al. Effect of Torcetrapib on the progression of coronary atherosclerosis. N Engl J Med 2007, 356:1304-1316.
7. Cao W., Calabro V., Root A., et al. Oligomerization is required for the activity of recombinant soluble LOX-1. FEBS J 2009, 276:4909-4920.
8. Zeibig S., Li Z., Wagner S., et al. Effect of the oxLDL binding protein Fc-CD68 on plaque extension and vulnerability in atherosclerosis. Circ Res 2011, 108:695-703.
9. McLaren J.E., Michael D.R., Ashlin T.G., Dipak P. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy. Prog Lipid Res 2011, 50:331-347.
10. Doran A.C., Meller N., McNamara C.A. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008, 28:812-819.
11. Gerthoffer W.T. Mechanisms of vascular smooth muscle cell migration. Circ Res 2007, 100:607-621.
12. Bennett M. Apoptosis of vascular smooth muscle cells in vascular remodelling and atherosclerotic plaque rupture. Cardiovasc Res 1999, 41:361-368.
13. Heissig B., Hattori K., Friedrich M., Rafii S., Werb Z. Angiogenesis: vascular remodeling of the extracellular matrix involves metalloproteinases. Curr Opin Hematol 2003, 10:136-141.
14. Bäck M., Ketelhuth D.F., Agewall S. Matrix metalloproteinases in atherothrombosis. Prog Cardiovasc Dis 2010, 52:410-428.
15. Godin D., Ivan E., Johnson C., Magid R., Galis Z.S. Remodeling of carotid artery is associated with increased expression of matrix metalloproteinases in mouse blood flow cessation model. Circulation 2000, 102:2861-2866.
16. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003, 92:827-839.
17. Dhore C.R., Cleutjens J.P., Lutgens E., et al. Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 2001, 21:1998-2003.
18. Csiszar A., Smith K.E., Koller A., et al. Regulation of bone morphogenetic protein-2 expression in endothelial cells: role of nuclear factor-kappa B activation by tumor necrosis factor-alpha, H2O2, and high intravascular pressure. Circulation 2005, 111:2364-2372.
19. Sorescu G.P., Song H., Tressel S.L., et al. Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress induces monocyte adhesion by stimulating reactive oxygen species production from a Nox1-based NADPH oxidase. Circ Res 2004, 95:773-779.
20. Nissen S.E., Gurley J.C., Grines C.L., et al. Intravascular ultrasound assessment of lumen size and wall morphology in normal subjects and patients with coronary artery disease. Circulation 1991, 84:1087-1099.
21. Casscells W., Hathorn B., David M.M., et al. Thermal detection of cellular infiltrates in living atherosclerotic plaques: possible implications for plaque rupture and thrombosis. Lancet 1996, 347:1447-1461.
22. Libby P., Ridker P.M., Hansson G.K. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009, 54:2129-2138. Leducq Transatlantic Network on Atherothrombosis.
23. Biasucci L.M., Biasillo G., Stefanelli A. Inflammatory markers, cholesterol and statins: pathophysiological role and clinical importance. Clin Chem Lab Med 2010, 48:1685-1691.
24. Ballantyne C.M., Nambi V. Markers of inflammation and their clinical significance. Atheroscler Suppl 2005, 6:21-29.
25. Maouche S., Schunkert H. Strategies beyond genome-wide association studies for atherosclerosis. Arterioscler Thromb Vasc Biol 2012, 32:170-181.